Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advaxis, Incorporated
Advaxis Engages the Numoda Corporation to Oversee Phase II Clinical Trials of ADXS11-001
July 10th, 2009
Advaxis, Incorporated (OTCBB: ADXS), has engaged the Numoda Corporation, a leading clinical trial and logistics management company, to oversee Phase II clinical activity with ADXS11-001 for the treatment of invasive cervix cancer and cervical intraepithelial neoplasia (CIN; cervical dysplasia). Numoda will integrate oversight and logistical functions with the clinical research organizations (CRO), contract laboratories, academic laboratories and statistical groups involved. "The Numoda Corporation offers experience and resources that will enable Advaxis to execute multiple high quality clinical trials with precision, efficiency, high quality data and...
Source: Health Business Week (2009-07-10)
|
